Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Week in Review: How Trump's policies moved stocks » 07:19
06/06/20
06/06
07:19
06/06/20
07:19
AZN

AstraZeneca

$53.87 /

+ (+0.00%)

, JNJ

Johnson & Johnson

$147.27 /

+0.61 (+0.42%)

, MRK

Merck

$82.26 /

+0.71 (+0.87%)

, MRNA

Moderna

$58.16 /

-2.44 (-4.03%)

, PFE

Pfizer

$35.97 /

-0.035 (-0.10%)

, INO

Inovio

$11.96 /

+0.09 (+0.76%)

, NVAX

Novavax

$46.22 /

+1.54 (+3.45%)

, AIRYY

Air China

$0.00 /

+ (+0.00%)

, CEA

China Eastern Airlines

$20.34 /

+1.54 (+8.19%)

, ZNH

China Southern Airlines

$25.21 /

+2.57 (+11.35%)

, AAL

American Airlines

$18.59 /

+1.855 (+11.08%)

, DAL

Delta Air Lines

$34.15 /

+1.77 (+5.47%)

, UAL

United Airlines

$42.41 /

+3.33 (+8.52%)

, SNAP

Snap

$20.32 /

+1.065 (+5.53%)

, FB

Facebook

$230.64 /

+4.38 (+1.94%)

, GOOG

Alphabet

$1,436.75 /

+24.625 (+1.74%)

, GOOGL

Alphabet Class A

$1,440.74 /

+26.62 (+1.88%)

, AAPL

Apple

$331.38 /

+9.09 (+2.82%)

, AMZN

Amazon.com

$2,481.08 /

+20.67 (+0.84%)

Catch up on the top…

Open Full Text

ShowHide Related Items >><<
AZN AstraZeneca
$53.87 /

+ (+0.00%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

PFE Pfizer
$35.97 /

-0.035 (-0.10%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

AIRYY Air China
$0.00 /

+ (+0.00%)

CEA China Eastern Airlines
$20.34 /

+1.54 (+8.19%)

ZNH China Southern Airlines
$25.21 /

+2.57 (+11.35%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

UAL United Airlines
$42.41 /

+3.33 (+8.52%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

06/04/20 UBS
AstraZeneca price target raised to 7,300 GBp from 6,000 GBp at UBS
06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$82.26 /

+0.71 (+0.87%)

06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
MRNA Moderna
$58.16 /

-2.44 (-4.03%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
PFE Pfizer
$35.97 /

-0.035 (-0.10%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
INO Inovio
$11.96 /

+0.09 (+0.76%)

06/04/20 Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
NVAX Novavax
$46.22 /

+1.54 (+3.45%)

06/05/20
Fly Intel: Top five analyst upgrades
06/05/20 JPMorgan
JPMorgan upgrades Novavax to Neutral despite 'shaky fundamentals'
06/05/20 B. Riley FBR
Novavax price target raised to $74 from $61 at B. Riley FBR
06/05/20 JPMorgan
Novavax upgraded to Neutral from Underweight at JPMorgan
AIRYY Air China
$0.00 /

+ (+0.00%)

03/18/20 Jefferies
Jefferies downgrades four China airlines on 'U-shaped' pandemic recovery
03/18/20 Jefferies
Air China downgraded to Underperform from Buy at Jefferies
03/09/20 Daiwa
Air China upgraded to Buy from Outperform at Daiwa
10/14/19 Goldman Sachs
Goldman upgrades China Southern to Buy on slower supply growth
CEA China Eastern Airlines
$20.34 /

+1.54 (+8.19%)

03/18/20 Jefferies
Jefferies downgrades four China airlines on 'U-shaped' pandemic recovery
03/18/20 Jefferies
China Eastern Airlines downgraded to Hold from Buy at Jefferies
12/20/19 Daiwa
China Eastern Airlines upgraded to Buy from Outperform at Daiwa
10/14/19 Goldman Sachs
Goldman upgrades China Southern to Buy on slower supply growth
ZNH China Southern Airlines
$25.21 /

+2.57 (+11.35%)

04/27/20 UBS
China Southern Airlines upgraded to Buy from Neutral at UBS
04/21/20 Credit Suisse
China Southern Airlines upgraded to Outperform from Neutral at Credit Suisse
03/18/20 Jefferies
Jefferies downgrades four China airlines on 'U-shaped' pandemic recovery
03/18/20 Jefferies
China Southern Airlines downgraded to Hold from Buy at Jefferies
AAL American Airlines
$18.59 /

+1.855 (+11.08%)

06/05/20 Credit Suisse
American stock reaction to demand commentary 'confounding,' says Credit Suisse
06/05/20
Fly Intel: Top five analyst downgrades
06/05/20 Raymond James
American Airlines downgraded to Underperform from Market Perform at Raymond James
06/05/20 Raymond James
American downgraded to Underperform from Market Perform at Raymond James
DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

06/05/20 Credit Suisse
American stock reaction to demand commentary 'confounding,' says Credit Suisse
05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
05/04/20 Barclays
Delta Air Lines downgraded to Equal Weight from Overweight at Barclays
04/23/20 Raymond James
Delta Air Lines price target lowered to $36 from $40 at Raymond James
UAL United Airlines
$42.41 /

+3.33 (+8.52%)

06/05/20 Credit Suisse
American stock reaction to demand commentary 'confounding,' says Credit Suisse
05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/19/20 Goldman Sachs
Southwest, United seeing modest improvements in demand, says Goldman Sachs
05/04/20 Barclays
Barclays downgrades U.S. Airlines sector along with American and Delta
SNAP Snap
$20.32 /

+1.065 (+5.53%)

06/01/20 Deutsche Bank
Snap price target raised to $24 from $18 at Deutsche Bank
05/06/20
Fly Intel: Top five analyst downgrades
05/06/20 Citi
Snap downgraded to Sell from Neutral at Citi
04/27/20 JMP Securities
Facebook Q1 should benefit from same headwinds as Snap, says JMP Securities
FB Facebook
$230.64 /

+4.38 (+1.94%)

05/29/20 Baird
Twitter, Facebook pullbacks would likely be buying opportunities, says Baird
05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

06/02/20 Wells Fargo
Microsoft price target raised to $250 from $205 at Wells Fargo
05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

06/02/20 Wells Fargo
Microsoft price target raised to $250 from $205 at Wells Fargo
05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/12/20 Citi
Alphabet price target raised to $1,600 from $1,400 at Citi
AAPL Apple
$331.38 /

+9.09 (+2.82%)

06/05/20 Credit Suisse
Apple price target raised to $295 from $260 at Credit Suisse
06/04/20 JPMorgan
'Way too early' for investors to write off Apple TV+, says JPMorgan
06/03/20 Bernstein
Apple could offer less expensive, easier to use Watch, says Bernstein
06/03/20 Morgan Stanley
Apple price target raised to $340 from $326 at Morgan Stanley
AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

06/05/20 DA Davidson
MongoDB price target raised to $215 from $105 at DA Davidson
06/05/20 SunTrust
eBay price target raised to $50 from $40 at SunTrust
06/05/20 RBC Capital
Slack Technologies price target raised to $38 from $28 at RBC Capital
06/05/20 JMP Securities
Domo price target raised to $35 from $22 at JMP Securities
AZN AstraZeneca
$53.87 /

+ (+0.00%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

PFE Pfizer
$35.97 /

-0.035 (-0.10%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

UAL United Airlines
$42.41 /

+3.33 (+8.52%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

PFE Pfizer
$35.97 /

-0.035 (-0.10%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

AIRYY Air China
$0.00 /

+ (+0.00%)

CEA China Eastern Airlines
$20.34 /

+1.54 (+8.19%)

ZNH China Southern Airlines
$25.21 /

+2.57 (+11.35%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

UAL United Airlines
$42.41 /

+3.33 (+8.52%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

PFE Pfizer
$35.97 /

-0.035 (-0.10%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

ZNH China Southern Airlines
$25.21 /

+2.57 (+11.35%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

UAL United Airlines
$42.41 /

+3.33 (+8.52%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

AZN AstraZeneca
$53.87 /

+ (+0.00%)

JNJ Johnson & Johnson
$147.27 /

+0.61 (+0.42%)

MRK Merck
$82.26 /

+0.71 (+0.87%)

MRNA Moderna
$58.16 /

-2.44 (-4.03%)

PFE Pfizer
$35.97 /

-0.035 (-0.10%)

INO Inovio
$11.96 /

+0.09 (+0.76%)

NVAX Novavax
$46.22 /

+1.54 (+3.45%)

AAL American Airlines
$18.59 /

+1.855 (+11.08%)

DAL Delta Air Lines
$34.15 /

+1.77 (+5.47%)

UAL United Airlines
$42.41 /

+3.33 (+8.52%)

SNAP Snap
$20.32 /

+1.065 (+5.53%)

FB Facebook
$230.64 /

+4.38 (+1.94%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

GOOG Alphabet
$1,436.75 /

+24.625 (+1.74%)

GOOGL Alphabet Class A
$1,440.74 /

+26.62 (+1.88%)

AAPL Apple
$331.38 /

+9.09 (+2.82%)

AMZN Amazon.com
$2,481.08 /

+20.67 (+0.84%)

Yesterday
Periodicals
Chevron oil cargo embroiled in U.S. sanctions on Venezuela, Reuters says » 14:05
06/05/20
06/05
14:05
06/05/20
14:05
CVX

Chevron

$100.97 /

+4.69 (+4.87%)

Chevron confirmed that…

Chevron confirmed that one of its crude oil cargo has become embroiled in U.S. sanctions on shipping companies for violating restrictions on doing business with Venezuela, Reuters' Jennifer Hiller, Devika Krishna Kumar, and Jonathan Saul report. Adamant Marine, owner of Seahero, was sanctioned by the U.S. Department of Treasury earlier this week for carrying a Venezuelan cargo earlier this year, the authors note. The vessel is on short-term charter and "performing a voyage that is not related to Venezuela," Chevron spokesman Ray Fohr told Reuters. "We are working with the appropriate government agencies to ensure compliance with U.S. laws and regulations," he added. Reference Link

ShowHide Related Items >><<
CVX Chevron
$100.97 /

+4.69 (+4.87%)

CVX Chevron
$100.97 /

+4.69 (+4.87%)

05/12/20 UBS
Chevron downgraded to Neutral from Buy at UBS
05/12/20 UBS
Chevron downgraded to Neutral from Buy at UBS
05/04/20
Fly Intel: Top five analyst downgrades
05/04/20 Craig-Hallum
Chevron price target raised to $100 from $81 at Craig-Hallum
CVX Chevron
$100.97 /

+4.69 (+4.87%)

CVX Chevron
$100.97 /

+4.69 (+4.87%)

CVX Chevron
$100.97 /

+4.69 (+4.87%)

CVX Chevron
$100.97 /

+4.69 (+4.87%)

General news
Fauci 'cautiously optimistic' at least one Phase 3 vaccine trial starts in July » 12:36
06/05/20
06/05
12:36
06/05/20
12:36
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$319.72 /

+8.42 (+2.70%)

, MRNA

Moderna

$57.29 /

-3.31 (-5.46%)

, JNJ

Johnson & Johnson

$148.84 /

+2.18 (+1.49%)

, MRK

Merck

$82.61 /

+1.06 (+1.30%)

, PFE

Pfizer

$36.11 /

+0.105 (+0.29%)

, NVAX

Novavax

$46.00 /

+1.32 (+2.95%)

, INO

Inovio

$11.43 /

-0.44 (-3.71%)

, AZN

AstraZeneca

$54.12 /

+0.25 (+0.46%)

Fauci said he is…

Fauci said he is "cautiously optimistic" that "at least one" Phase 3 trial testing a COVID_19 vaccine candidate can start in early July and that "a few others" should be able to start by early fall. If things break correctly, "we can have an answer" by the end of this calendar year or early in 2021 if there is a safe and effective vaccine that has been found, added Fauci. Companies working on potential COVID-19 vaccines include Moderna (MRNA), AstraZeneca (AZN), Johnson & Johnson (JNJ), Merck (MRK), Pfizer (PFE), Novavax (NVAX) and Inovio (INO). Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, is being interviewed on CNBC.

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$82.61 /

+1.06 (+1.30%)

06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
PFE Pfizer
$36.11 /

+0.105 (+0.29%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
NVAX Novavax
$46.00 /

+1.32 (+2.95%)

06/05/20
Fly Intel: Top five analyst upgrades
06/05/20 JPMorgan
JPMorgan upgrades Novavax to Neutral despite 'shaky fundamentals'
06/05/20 B. Riley FBR
Novavax price target raised to $74 from $61 at B. Riley FBR
06/05/20 JPMorgan
Novavax upgraded to Neutral from Underweight at JPMorgan
INO Inovio
$11.43 /

-0.44 (-3.71%)

06/04/20 Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

06/04/20 UBS
AstraZeneca price target raised to 7,300 GBp from 6,000 GBp at UBS
06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
Medtronic recieves CE Mark for one-month DAPT indication for Resolute Onyx DES » 09:03
06/05/20
06/05
09:03
06/05/20
09:03
MDT

Medtronic

$96.97 /

-0.13 (-0.13%)

Medtronic announced it…

Medtronic announced it has received CE Mark for a one-month dual antiplatelet therapy indication for high bleeding risk (HBR) patients implanted with the Resolute Onyx Drug-Eluting Stent. For HBR patients, whose bleeding risk may be increased by taking longer DAPT regimens, this new, first-of-its-kind indication allows physicians to recommend a shorter, one-month regimen of DAPT, following a percutaneous coronary intervention with Resolute Onyx. The approval is the first of its kind globally. Resolute Onyx DES is available for use in the United States, as well as in Europe and other countries that recognize the CE Mark. Resolute Onyx DES is not currently indicated for HBR patients with one-month DAPT in the United States. Data have been submitted to the FDA with the intent of obtaining a one-month DAPT US Indication for Resolute Onyx DES. The indication is based on results from the Onyx ONE Global Study, the first prospective, randomized, one-month DAPT trial comparing Resolute Onyx to a competitive DES in nearly 2,000 HBR patients. In the study, Resolute Onyx met its primary composite endpoint of cardiac death, myocardial infarction or stent thrombosis at one-year showing non-inferiority versus BioFreedom DCS. Results from the global study were shared during a Late-Breaking Clinical Trial session at the 31st Transcatheter Cardiovascular Therapeutics Conference in September 2019 and were also published in the New England Journal of Medicine. The Onyx ONE Global Study, together with the Onyx ONE Clear Study, a study that evaluated Resolute Onyx DES in HBR patients with one-month DAPT in the United States and Japan, make up the robust Medtronic Onyx ONE Month DAPT Program that has enrolled approximately 2,700 patients at up to 130 sites worldwide. To date, more than 22,000 patients have been studied in Medtronic sponsored and funded clinical trials that have addressed DAPT duration.

ShowHide Related Items >><<
MDT Medtronic
$96.97 /

-0.13 (-0.13%)

MDT Medtronic
$96.97 /

-0.13 (-0.13%)

05/26/20 SunTrust
Medtronic price target lowered to $105 from $130 at SunTrust
05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
MDT Medtronic
$96.97 /

-0.13 (-0.13%)

MDT Medtronic
$96.97 /

-0.13 (-0.13%)

MDT Medtronic
$96.97 /

-0.13 (-0.13%)

MDT Medtronic
$96.97 /

-0.13 (-0.13%)

Thursday
Hot Stocks
Halozyme announces marketing authorization for subcutaneous Darzalex » 12:40
06/04/20
06/04
12:40
06/04/20
12:40
HALO

Halozyme

$23.45 /

-0.16 (-0.68%)

, JNJ

Johnson & Johnson

$146.27 /

-2.41 (-1.62%)

Halozyme Therapeutics…

Halozyme Therapeutics (HALO) announced that the European Commission has granted Janssen-Cilag International (JNJ) marketing authorization for the subcutaneous formulation of Darzalex, for the treatment of adult patients with multiple myeloma in all currently approved Darzalex intravenous formulation indications in frontline and relapsed / refractory settings. The approval follows a Positive Opinion by the CHMP of the European Medicines Agency in April 2020. The subcutaneous formulation is administered as a fixed-dose over approximately three to five minutes, less time than IV Darzalex, which is given over several hours, the company said in a statement.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$146.27 /

-2.41 (-1.62%)

HALO Halozyme
$23.45 /

-0.16 (-0.68%)

HALO Halozyme
$23.45 /

-0.16 (-0.68%)

05/26/20 Piper Sandler
Halozyme's Enhanze business nearing accelerated growth, says Piper Sandler
05/12/20 JMP Securities
Halozyme price target raised to $34 from $24 at JMP Securities
05/04/20 Cantor Fitzgerald
Halozyme price target raised to $39 from $35 at Cantor Fitzgerald
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
JNJ Johnson & Johnson
$146.27 /

-2.41 (-1.62%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
JNJ Johnson & Johnson
$146.27 /

-2.41 (-1.62%)

HALO Halozyme
$23.45 /

-0.16 (-0.68%)

JNJ Johnson & Johnson
$146.27 /

-2.41 (-1.62%)

JNJ Johnson & Johnson
$146.27 /

-2.41 (-1.62%)

HALO Halozyme
$23.45 /

-0.16 (-0.68%)

JNJ Johnson & Johnson
$146.27 /

-2.41 (-1.62%)

On The Fly
Inovio, Novavax analysts undeterred by White House vaccine snub » 11:12
06/04/20
06/04
11:12
06/04/20
11:12
INO

Inovio

$12.52 /

+0.07 (+0.56%)

, NVAX

Novavax

$44.38 /

+0.12 (+0.27%)

, MRNA

Moderna

$59.95 /

+0.065 (+0.11%)

, AZN

AstraZeneca

$54.45 /

-0.55 (-1.00%)

, JNJ

Johnson & Johnson

$146.14 /

-2.54 (-1.71%)

, MRK

Merck

$81.26 /

-0.81 (-0.99%)

, PFE

Pfizer

$35.97 /

-0.185 (-0.51%)

Shares of Inovio…

Open Full Text

ShowHide Related Items >><<
PFE Pfizer
$35.97 /

-0.185 (-0.51%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

06/04/20 Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
NVAX Novavax
$44.38 /

+0.12 (+0.27%)

06/03/20 B. Riley FBR
Novavax selloff on 'Warp Speed' report unwarranted, says B. Riley FBR
05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
MRNA Moderna
$59.95 /

+0.065 (+0.11%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$81.26 /

-0.81 (-0.99%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
PFE Pfizer
$35.97 /

-0.185 (-0.51%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
PFE Pfizer
$35.97 /

-0.185 (-0.51%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

PFE Pfizer
$35.97 /

-0.185 (-0.51%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

PFE Pfizer
$35.97 /

-0.185 (-0.51%)

NVAX Novavax
$44.38 /

+0.12 (+0.27%)

MRNA Moderna
$59.95 /

+0.065 (+0.11%)

MRK Merck
$81.26 /

-0.81 (-0.99%)

JNJ Johnson & Johnson
$146.14 /

-2.54 (-1.71%)

INO Inovio
$12.52 /

+0.07 (+0.56%)

AZN AstraZeneca
$54.45 /

-0.55 (-1.00%)

Hot Stocks
Titan Medical announces development, license agreements with Medtronic » 07:40
06/04/20
06/04
07:40
06/04/20
07:40
TMDI

Titan Medical

$0.28 /

+0.0064 (+2.37%)

, MDT

Medtronic

$97.10 /

-0.06 (-0.06%)

Titan Medical (TMDI)…

Titan Medical (TMDI) announces that it has entered into a development and license agreement with Medtronic (MDT) to further the development of robotic assisted surgical technologies, as well as a separate license agreement with Medtronic in respect of certain intellectual property of Titan. Titan said in a release, "The development and license agreement provides for the development of robotic assisted surgical technologies for use by both Titan and Medtronic in their respective businesses. Titan will receive a series of payments totaling up to U.S. $31 million for Medtronic's license to such technologies, as technology milestones are completed and verified. A steering committee comprised of representatives from Titan and Medtronic will be established to provide oversight regarding the work toward achievement of the milestones. One of the milestones of the agreement is for Titan to raise an additional U.S. $18 million of capital within four months of the development start date, which is expected to occur in June 2020. To support development, Titan has received a senior secured loan of U.S. $1.5 million from Medtronic which was announced on April 29, 2020. The loan, which will be increased by an amount equal to certain legal, transaction and intellectual property related expenses pursuant to the definitive agreements, will be evidenced by an amended and restated promissory note, and will bear interest at the rate of 8% per annum. The loan is repayable on June 4, 2023, or upon the earlier completion of the last milestone under the development and license agreement or a Change of Control of Titan (as defined in the note). Until repayment of the loan, Medtronic may have one non-voting observer attend meetings of Titan's Board of Directors. The loan will be secured by way of a security agreement entered into by Titan and pursuant to which Titan has granted a security interest in favor of Medtronic in all of Titan's present and future property including all personal property, inventory, equipment and intellectual property. Under the terms of the separate license agreement, Medtronic has licensed certain robotic assisted surgical technologies from Titan for an upfront payment of U.S. $10 million. Titan retains the rights to continue to develop and commercialize those technologies for its own business."

ShowHide Related Items >><<
TMDI Titan Medical
$0.28 /

+0.0064 (+2.37%)

MDT Medtronic
$97.10 /

-0.06 (-0.06%)

TMDI Titan Medical
$0.28 /

+0.0064 (+2.37%)

03/31/20 Piper Sandler
Titan Medical price target lowered to $1 from $1.50 at Piper Sandler
12/23/19 Piper Sandler
Titan Medical price target cut to $1.50 from $2.50 at Piper Jaffray
11/18/19 Piper Sandler
Titan Medical transferred with an Overweight rating at Piper Jaffray
10/16/19 Maxim
Titan Medical downgraded to Hold from Buy at Maxim
MDT Medtronic
$97.10 /

-0.06 (-0.06%)

05/26/20 SunTrust
Medtronic price target lowered to $105 from $130 at SunTrust
05/21/20 Piper Sandler
Medtronic price target lowered to $120 from $135 at Piper Sandler
05/21/20 Piper Sandler
Medtronic robot delay positive for Intuitive Surgical, says Piper Sandler
05/14/20 DZ Bank
Medtronic downgraded to Hold from Buy at DZ Bank
MDT Medtronic
$97.10 /

-0.06 (-0.06%)

MDT Medtronic
$97.10 /

-0.06 (-0.06%)

MDT Medtronic
$97.10 /

-0.06 (-0.06%)

MDT Medtronic
$97.10 /

-0.06 (-0.06%)

Wednesday
On The Fly
Fly Intel: Wall Street's top stories for Wednesday » 16:34
06/03/20
06/03
16:34
06/03/20
16:34
ZM

Zoom Video

$223.91 /

+15.91 (+7.65%)

, CRWD

Crowdstrike

$98.11 /

+5.945 (+6.45%)

, WMG

Warner Music

$30.07 /

+ (+0.00%)

, PLRX

Pliant Therapeutics

$21.35 /

+ (+0.00%)

, MRNA

Moderna

$59.89 /

+0.005 (+0.01%)

, INO

Inovio

$12.43 /

-1.94 (-13.50%)

, NVAX

Novavax

$44.26 /

-5.315 (-10.72%)

, AZN

AstraZeneca

$55.00 /

+0.285 (+0.52%)

, MRK

Merck

$82.07 /

+1.22 (+1.51%)

, JNJ

Johnson & Johnson

$148.68 /

+0.52 (+0.35%)

, PFE

Pfizer

$36.15 /

-0.01 (-0.03%)

, SNAP

Snap

$19.73 /

-0.035 (-0.18%)

, CAKE

Cheesecake Factory

$24.35 /

+3.41 (+16.28%)

, CRTO

Criteo

$13.26 /

+2.08 (+18.60%)

, ROKU

Roku

$103.90 /

-6.92 (-6.24%)

, BBY

Best Buy

$82.23 /

+1.76 (+2.19%)

, PPC

Pilgrim's Pride

$18.30 /

-2.58 (-12.36%)

Stocks continue to find…

Open Full Text

ShowHide Related Items >><<
ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

WMG Warner Music
$30.07 /

+ (+0.00%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CRTO Criteo
$13.26 /

+2.08 (+18.60%)

CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

06/03/20
Fly Intel: Top five analyst upgrades
06/03/20 Needham
Zoom Video price target raised to $230 from $140 at Needham
06/03/20 FBN Securities
Zoom Video upgraded to Outperform from Sector Perform at FBN Securities
06/03/20 JPMorgan
Wowed JPMorgan raises Zoom Video price target to $220 from $150
CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

06/03/20 JPMorgan
Crowdstrike price target raised to $120 from $109 at JPMorgan
06/03/20 BTIG
Crowdstrike price target raised to $115 from $80 at BTIG
06/03/20 DA Davidson
Crowdstrike price target raised to $120 from $105 at DA Davidson
06/03/20 Oppenheimer
Crowdstrike price target raised to $110 from $85 at Oppenheimer
WMG Warner Music
$30.07 /

+ (+0.00%)

06/03/20
Fly Intel: Top five analyst initiations
06/03/20 Atlantic Equities
Warner Music initiated with a Neutral at Atlantic Equities
PLRX Pliant Therapeutics
$21.35 /

+ (+0.00%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
INO Inovio
$12.43 /

-1.94 (-13.50%)

06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
05/20/20 Piper Sandler
Piper Sandler stays Neutral on Inovio, offers a 'little perspective' on vaccine
NVAX Novavax
$44.26 /

-5.315 (-10.72%)

06/03/20 B. Riley FBR
Novavax selloff on 'Warp Speed' report unwarranted, says B. Riley FBR
05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
MRK Merck
$82.07 /

+1.22 (+1.51%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
PFE Pfizer
$36.15 /

-0.01 (-0.03%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
SNAP Snap
$19.73 /

-0.035 (-0.18%)

06/01/20 Deutsche Bank
Snap price target raised to $24 from $18 at Deutsche Bank
05/06/20
Fly Intel: Top five analyst downgrades
05/06/20 Citi
Snap downgraded to Sell from Neutral at Citi
04/27/20 JMP Securities
Facebook Q1 should benefit from same headwinds as Snap, says JMP Securities
CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

06/03/20 Stephens
Stephens stays Underweight Cheesecake Factory after reopening update
05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 Stephens
Cheesecake Factory resumed Underweight from Equal Weight at Stephens
05/07/20 Loop Capital
Cheesecake Factory price target lowered to $23 from $44 at Loop Capital
CRTO Criteo
$13.26 /

+2.08 (+18.60%)

05/08/20 Deutsche Bank
Criteo price target lowered to $16 from $22 at Deutsche Bank
05/05/20 SunTrust
Criteo price target lowered to $13 from $25 at SunTrust
04/20/20 Nomura Instinet
Criteo price target lowered to $10 from $14 at Nomura Instinet
04/08/20 Societe Generale
Criteo upgraded to Buy from Hold at Societe Generale
ROKU Roku
$103.90 /

-6.92 (-6.24%)

06/03/20 Stephens
Roku may be seeing pressure from Best Buy TCL TVs, says Stephens
06/03/20 SunTrust
New TVs at Best Buy present 'modest' new competition for Roku, says Suntrust
05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Stephens
Roku downgraded to Equal Weight on worries about TCL at Stephens
BBY Best Buy
$82.23 /

+1.76 (+2.19%)

05/22/20 Loop Capital
Best Buy price target raised to $90 from $80 at Loop Capital
05/22/20 Morgan Stanley
Best Buy price target raised to $85 from $75 at Morgan Stanley
PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

06/03/20 Stephens
Stephens downgrades Pilgrim's Pride after indictment, suspends targets on peers
06/03/20 Stephens
Pilgrim's Pride downgraded to Equal Weight from Overweight at Stephens
05/11/20 Stephens
Stephens upgrades Pilgrim's Pride, says navigating current environment well
05/11/20 Stephens
Pilgrim's Pride upgraded to Overweight from Equal Weight at Stephens
ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CRTO Criteo
$13.26 /

+2.08 (+18.60%)

CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

  • 03
    Jun
  • 03
    Jun
ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

WMG Warner Music
$30.07 /

+ (+0.00%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

WMG Warner Music
$30.07 /

+ (+0.00%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PPC Pilgrim's Pride
$18.30 /

-2.58 (-12.36%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CRTO Criteo
$13.26 /

+2.08 (+18.60%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

ZM Zoom Video
$223.91 /

+15.91 (+7.65%)

SNAP Snap
$19.73 /

-0.035 (-0.18%)

ROKU Roku
$103.90 /

-6.92 (-6.24%)

PFE Pfizer
$36.15 /

-0.01 (-0.03%)

NVAX Novavax
$44.26 /

-5.315 (-10.72%)

MRNA Moderna
$59.89 /

+0.005 (+0.01%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

JNJ Johnson & Johnson
$148.68 /

+0.52 (+0.35%)

INO Inovio
$12.43 /

-1.94 (-13.50%)

CRWD Crowdstrike
$98.11 /

+5.945 (+6.45%)

CAKE Cheesecake Factory
$24.35 /

+3.41 (+16.28%)

BBY Best Buy
$82.23 /

+1.76 (+2.19%)

AZN AstraZeneca
$55.00 /

+0.285 (+0.52%)

On The Fly
Moderna rises, Novavax plunges as White House names COVID finalists » 14:17
06/03/20
06/03
14:17
06/03/20
14:17
MRNA

Moderna

$60.70 /

+0.82 (+1.37%)

, INO

Inovio

$12.48 /

-1.89 (-13.15%)

, NVAX

Novavax

$42.29 /

-7.28 (-14.69%)

, AZN

AstraZeneca

$55.25 /

+0.535 (+0.98%)

, JNJ

Johnson & Johnson

$148.00 /

-0.16 (-0.11%)

, MRK

Merck

$82.13 /

+1.28 (+1.58%)

, PFE

Pfizer

$35.97 /

-0.19 (-0.53%)

Shares of Moderna (MRNA)…

Open Full Text

ShowHide Related Items >><<
PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
INO Inovio
$12.48 /

-1.89 (-13.15%)

06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
05/20/20 Piper Sandler
Piper Sandler stays Neutral on Inovio, offers a 'little perspective' on vaccine
NVAX Novavax
$42.29 /

-7.28 (-14.69%)

06/03/20 B. Riley FBR
Novavax selloff on 'Warp Speed' report unwarranted, says B. Riley FBR
05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$82.13 /

+1.28 (+1.58%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
PFE Pfizer
$35.97 /

-0.19 (-0.53%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

PFE Pfizer
$35.97 /

-0.19 (-0.53%)

NVAX Novavax
$42.29 /

-7.28 (-14.69%)

MRNA Moderna
$60.70 /

+0.82 (+1.37%)

MRK Merck
$82.13 /

+1.28 (+1.58%)

JNJ Johnson & Johnson
$148.00 /

-0.16 (-0.11%)

INO Inovio
$12.48 /

-1.89 (-13.15%)

AZN AstraZeneca
$55.25 /

+0.535 (+0.98%)

Periodicals
Novavax sinks after White House omits as COVID vaccine finalist » 13:16
06/03/20
06/03
13:16
06/03/20
13:16
MRK

Merck

$81.74 /

+0.89 (+1.10%)

, AZN

AstraZeneca

$54.71 /

-0.005 (-0.01%)

, PFE

Pfizer

$35.72 /

-0.44 (-1.22%)

, JNJ

Johnson & Johnson

$147.44 /

-0.72 (-0.49%)

, MRNA

Moderna

$59.63 /

-0.25 (-0.42%)

, NVAX

Novavax

$48.10 /

-1.47 (-2.97%)

The New York Times this…

The New York Times this afternoon reported that Moderna (MRNA) is among the five finalists selected by the Trump administration as the most likely to produce a vaccine for the coronavirus. By narrowing the field, the White House is betting it can identify the most promising vaccines at an early stage, speed along the process of determining which will work and ensure that the winner or winners can be quickly manufactured in large quanities, the Times said. A White House announcement is expected in the new few weeks. In addition to Moderna, the winners are AstraZeneca (AZN), Johnson & Johnson (JNJ), Merck (MRK) and Pfizer (PFE), according the Times. Shares of Moderna are down 11c to $59.76 in afternoon trading. Novavax (NVAX) shares are down 14% to $42.60 after not being selected as a finalist.

ShowHide Related Items >><<
PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
PFE Pfizer
$35.72 /

-0.44 (-1.22%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRNA Moderna
$59.63 /

-0.25 (-0.42%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
NVAX Novavax
$48.10 /

-1.47 (-2.97%)

05/26/20 B. Riley FBR
Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
05/18/20 B. Riley FBR
Novavax price target raised to $53 from $43 at B. Riley FBR
05/14/20 Ladenburg
Novavax price target raised to $50 from $38 at Ladenburg
05/12/20 B. Riley FBR
Novavax price target raised to $43 from $29 at B. Riley FBR
PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

PFE Pfizer
$35.72 /

-0.44 (-1.22%)

NVAX Novavax
$48.10 /

-1.47 (-2.97%)

MRNA Moderna
$59.63 /

-0.25 (-0.42%)

MRK Merck
$81.74 /

+0.89 (+1.10%)

JNJ Johnson & Johnson
$147.44 /

-0.72 (-0.49%)

AZN AstraZeneca
$54.71 /

-0.005 (-0.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.